Aug 9 (Reuters) - Cardiome Pharma Corp COM.TO
* Cardiome announces XYDALBA single dose infusion approval by european medicines agency
* Anticipate XYDALB will be available to physicians within some of major territories under license by cardiome during q4 of 2016 Source text for Eikon: ID:nCNWQ62Yfa Further company coverage: COM.TO